Insider trades
Scott L. Burrows, CFO of Spyre Therapeutics SYRE, has filed 0 purchases and 16 sales on the open market. Over the past 12 months that comes to a net sale of $3.2M. The latest trade was on 06/25.
Scott L. Burrows
CFO
- Company
- Spyre Therapeutics SYRE
- First filing
- 23/03/02
- Trades
- 33 trades
- Buys / sales
- 0 / 16
- 12-month net buying
- −$3.2M
- Last trade
- 06/25
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
SYRE | Open-market sale | 06/25 | 06/26 | 15,000 sh2 trades | $87.13avg. | $1,307,000 | −13.3% |
SYRE | Open-market sale10b5-1 plan | 06/01 | 06/03 | 7,500 sh3 trades | $71.06avg. | $532,936.98 | −7.1% |
| Open-market sale10b5-1 plan | 05/01 | 05/01 | 12,500 sh | $71.37 | $892,125 | −11.3% | |
SYRE | Open-market sale10b5-1 plan | 04/01 | 04/03 | 7,500 sh2 trades | $49.34avg. | $370,076 | −7.1% |
SYRE | Open-market sale10b5-1 plan | 03/03 | 03/03 | 2,500 sh2 trades | $40.65avg. | $101,620 | −2.5% |
| Open-market sale | 25/09/02 | 25/09/03 | 18,428 sh | $16.26 | $299,639.28 | −15.8% | |
| Open-market sale | 24/09/03 | 24/09/05 | 18,531 sh | $28.17 | $522,018.27 | −13.7% | |
| Open-market sale | 23/03/06 | 23/03/08 | 291 sh | $15.26 | $4,440.66 | −0.5% | |
ARQT | Open-market sale | 23/02/28–23/03/02 | 23/03/02 | 1,850 sh3 trades | $15.91avg. | $29,425.2 | −4.6% |
